{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-147339","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2025-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.853743+00:00","generated_at":"2026-05-18T18:13:30.380569+00:00","sec_items":["1.01","1.02","3.02","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Vor Bio licenses telitacicept from RemeGen for $125M upfront, raises $175M PIPE, appoints new CEO","bullets":["License deal: Vor Bio gets ex-China rights to telitacicept (global Phase 3 for gMG) for $125M upfront ($45M cash + $80M warrants); up to $4B+ milestones plus royalties.","Private Placement: $175M gross from pre-funded warrants to buy 700M shares at $0.25/warrant; closing expected June 27, 2025.","CEO change: Robert Ang resigned; Jean-Paul Kress (ex-MorphoSys CEO) appointed CEO and Chairman. Dr. Ang stays as advisor through October.","Cambridge lease terminated: $8.5M termination fee paid; $2.4M letter of credit to be returned. Lease was set to expire in 2030.","Stockholders representing ~63% voting power signed support agreements to approve share issuance and charter amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-147339","json":"https://secwatch.observer/filing/0001193125-25-147339.json","markdown":"https://secwatch.observer/filing/0001193125-25-147339.md","text":"https://secwatch.observer/filing/0001193125-25-147339.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525147339/0001193125-25-147339-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525147339/d27026d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T18:13:30.380569+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}